Advertisement
Screener

Faeth Therapeutics, Inc. (FTH) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Faeth Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Faeth Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $20.45M went out.
  • Fiscal year ended 2025-12-31: from investing, $19.77M came in.
  • Fiscal year ended 2025-12-31: from financing, $645.00K went out.
  • Fiscal year ended 2025-12-31: change in cash, $1.33M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$20.45M$19.77M-$3.00K$2.00K-$644.00K*-$1.33M
2024-12-31-$24.67M$22.44M-$10.00K$0.00-$777.00K*-$3.02M
2023-12-31-$32.02M$38.41M-$10.38M-$76.00K-$713.00K*-$4.78M
2022-12-31-$39.03M$49.95M$238.00K*$10.64M
2021-12-31-$30.26M-$143.12M$29.00K$163.91M*-$9.44M
2020-12-31-$17.70M-$1.40M$35.45M*$16.34M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$15.67M*-$108.07M*$0.00*$98.00K*-$1.78M*
2026-03-31-$10.73M-$31.44M$0.00$1.03M$184.79M*$143.66M
2025-12-31-$3.86M*$2.08M*$0.00*
2025-09-30-$3.59M*$1.74M*$0.00*
2025-06-30-$5.91M*$8.76M*$0.00*$0.00*
2025-03-31-$7.09M$7.19M-$3.00K$0.00-$117.00K
2024-12-31-$5.79M*-$3.15M*$0.00*
2024-09-30-$5.47M*$12.91M*$0.00*
2024-06-30-$5.79M*$6.91M*$0.00*
2024-03-31-$7.62M$5.77M-$10.00K-$2.06M
2023-12-31-$6.16M*$8.26M*-$252.00K*$0.00*
2023-09-30-$4.66M*$8.31M*-$2.34M*$0.00*
2023-06-30-$9.46M*$19.53M*$0.00*-$7.95M*
2023-03-31-$11.74M$2.31M-$76.00K-$9.69M
2022-12-31-$9.57M*$16.04M*$0.00*
2022-09-30-$6.80M*$8.52M*
2022-06-30-$11.90M*$13.20M*
2022-03-31-$10.75M$12.19M$238.00K$1.56M
2021-12-31-$7.87M*$5.61M*$28.00K*
2021-09-30-$5.58M*-$482.00K*$0.00*
2021-06-30-$6.05M*-$147.76M*$0.00*
2021-03-31-$10.77M-$487.00K$1.00K$164.07M*$152.82M
2020-12-31-$2.68M*-$316.00K*$15.86M*
2020-09-30-$5.80M*-$836.00K*$8.48M*
2020-06-30-$2.77M*-$199.00K*$556.00K*
2020-03-31-$6.46M-$52.00K$10.56M*$4.04M

Similar stocks

Stock NameCountryMarket CapPE Ratio
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Verastem, Inc. (VSTM)United States$0.706B-1.71
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
GERON CORP (GERN)United States$0.803B-12.14
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Climb Bio, Inc. (CLYM)United States$0.683B-13.03